Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab for Low Vision in Neovascular AMD
NCT01327222Phase 3Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Feb 2011
- Primary completion
- Feb 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of bevacizumab in neovascular age-related macular degeneration (NVAMD), sponsored by IRCCS Ospedale San Raffaele. Started Feb 2011; status: completed.
02
Drugs
bevacizumab
03
Conditions
neovascular age-related macular degeneration (NVAMD)
Beyond the preview
Go deeper on NCT01327222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01327222.